MNOV - Medicinova, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.43 0.01 (0.44%) --- --- 0.0 (-0.26%) --- 0.01 (0.44%) --- ---

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.07
Diluted EPS:
-0.07
Basic P/E:
-20.5186
Diluted P/E:
-20.5186
RSI(14) 1m:
0.0
VWAP:
1.44
RVol:

Events

Period Kind Movement Occurred At

Related News